| Dr Suemoy S Wallace, MD | |
|
2945 S Dobson Rd, Mesa, AZ 85202-7941 | |
| (480) 969-4138 | |
| (480) 969-0630 |
| Full Name | Dr Suemoy S Wallace |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 20 Years |
| Location | 2945 S Dobson Rd, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184850885 | NPI | - | NPPES |
| 948235 | Medicaid | AZ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mountain Vista Medical Center, Lp | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physician Group Of Arizona Inc | 1456439967 | 32 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Entity Name | Honorhealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801092564 PECOS PAC ID: 1456258607 Enrollment ID: O20031216000350 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Entity Name | Physician Group Of Arizona Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518137520 PECOS PAC ID: 1456439967 Enrollment ID: O20080424000348 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Entity Name | Acute Care Surgical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225311871 PECOS PAC ID: 7315106416 Enrollment ID: O20120308000890 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Entity Name | Banner Hospital Based Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275889891 PECOS PAC ID: 3274782487 Enrollment ID: O20121003000752 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Entity Name | Banner - University Hospital Based Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750751566 PECOS PAC ID: 1052614294 Enrollment ID: O20160122000508 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Entity Name | Arizona Acute Medical Services 1 Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154860674 PECOS PAC ID: 6204113970 Enrollment ID: O20170505001284 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Entity Name | Dragha Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205491826 PECOS PAC ID: 1052390259 Enrollment ID: O20190723000247 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Entity Name | Arizona Advanced Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346880838 PECOS PAC ID: 0547690166 Enrollment ID: O20200423000406 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Entity Name | Mohave Intensivist Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891386710 PECOS PAC ID: 2567879638 Enrollment ID: O20210408000395 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Suemoy S Wallace, MD 2320 N 3rd St, Phoenix, AZ 85004-1303 Ph: (480) 969-4138 | Dr Suemoy S Wallace, MD 2945 S Dobson Rd, Mesa, AZ 85202-7941 Ph: (480) 969-4138 |
News Archive
The U.S. Food and Drug Administration today approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke by making it less likely that platelets in the blood will clump and form clots in the arteries.
Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.
Global nanotechnology company pSivida Limited, is pleased to announce that its UK operating subsidiary pSiMedica Limited has been granted a new Australian patent for BioSiliconTM.
Bone disease is becoming increasingly prevalence in modern society due to population aging amongother factors, and the use of dental and orthopedic implants to treat bone disease has been on the rise.
› Verified 5 days ago